These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14760126)

  • 41. Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine).
    Fields MT; Eisbruch A; Normolle D; Orfali A; Davis MA; Pu AT; Lawrence TS
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):785-91. PubMed ID: 10837965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Final report of a pilot trial of accelerated radiotherapy plus concurrent 96-hour infusional paclitaxel for locally advanced head and neck cancer.
    Bucci MK; Rosenthal DI; Hershock D; Metz J; Devine P; Kligerman MM; Machtay M
    Am J Clin Oncol; 2004 Dec; 27(6):595-602. PubMed ID: 15577438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas.
    Medina JA; Rueda A; de Pasos AS; Contreras J; Cobo M; Moreno P; Benavides M; Villanueva A; Alba E
    Radiother Oncol; 2006 Apr; 79(1):34-8. PubMed ID: 16626826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phase II study of gemcitabine in gallbladder carcinoma.
    Gallardo JO; Rubio B; Fodor M; Orlandi L; Yáñez M; Gamargo C; Ahumada M
    Ann Oncol; 2001 Oct; 12(10):1403-6. PubMed ID: 11762811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma.
    Pattaranutaporn P; Thirapakawong C; Chansilpa Y; Therasakvichya S; Ieumwananontachai N; Thephamongkhol K
    Gynecol Oncol; 2001 Jun; 81(3):404-7. PubMed ID: 11371129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gemcitabine in the treatment of advanced head and neck cancer.
    Raguse JD; Gath HJ; Bier J; Riess H; Oettle H
    Clin Oncol (R Coll Radiol); 2005 Sep; 17(6):425-9. PubMed ID: 16149285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
    Milano MT; Vokes EE; Salama JK; Stenson KM; Kao J; Witt ME; Mittal BB; Argiris A; Weichselbaum RR; Haraf DJ
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1096-106. PubMed ID: 15752889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Concurrent chemoradiotherapy for head and neck squamous cell carcinoma with indication of total laryngectomy].
    Kubota A; Furukawa M; Komatsu M
    Nihon Jibiinkoka Gakkai Kaiho; 2004 Nov; 107(11):1004-10. PubMed ID: 15624506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck.
    Biete Solà A; Marruecos Querol J; Calvo Manuel FA; Verger Fransoy E; Rovirosa Casino A; Grau de Castro JJ; de Las Heras González M; Ramos Aguerri A; Palacios Eito A; Veiras Candal C; Solano López MV
    Clin Transl Oncol; 2007 Apr; 9(4):244-50. PubMed ID: 17462977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.
    Gurka MK; Collins SP; Slack R; Tse G; Charabaty A; Ley L; Berzcel L; Lei S; Suy S; Haddad N; Jha R; Johnson CD; Jackson P; Marshall JL; Pishvaian MJ
    Radiat Oncol; 2013 Mar; 8():44. PubMed ID: 23452509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial.
    Vormittag L; Lemaire C; Radonjic D; Kornek G; Selzer E
    Strahlenther Onkol; 2012 Mar; 188(3):235-42. PubMed ID: 22318328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
    Crane CH; Abbruzzese JL; Evans DB; Wolff RA; Ballo MT; Delclos M; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Vauthey JN; Wong AB; Phan T; Nguyen Q; Janjan NA
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1293-302. PubMed ID: 11955742
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer.
    Kao J; Genden EM; Gupta V; Policarpio EL; Burri RJ; Rivera M; Gurudutt V; Som PM; Teng M; Packer SH
    Cancer; 2011 Jan; 117(2):318-26. PubMed ID: 20830768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II study.
    Samlowski WE; Gundacker H; Kuebler JP; Giguere JK; Mills GM; Schuller DE; Ensley JF
    Invest New Drugs; 2001; 19(4):311-5. PubMed ID: 11561690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
    Colucci G; Giuliani F; Gebbia V; Biglietto M; Rabitti P; Uomo G; Cigolari S; Testa A; Maiello E; Lopez M
    Cancer; 2002 Feb; 94(4):902-10. PubMed ID: 11920457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
    Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ
    Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer.
    Sunwoo JB; Herscher LL; Kroog GS; Thomas GR; Ondrey FG; Duffey DC; Solomon BI; Boss C; Albert PS; McCullugh L; Rudy S; Muir C; Zhai S; Figg WD; Cook JA; Mitchell JB; Van Waes C
    J Clin Oncol; 2001 Feb; 19(3):800-11. PubMed ID: 11157034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
    Shepherd FA; Cormier Y; Burkes R; Evans WK; Goss G; Klimo P; Feld R; Taylor M
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Concurrent radiotherapy and continuous ambulatory infusion 5-fluorouracil in advanced head and neck cancer.
    Olver IN; Hughes PG; Smith JG; Narayan K; Bishop JF
    Eur J Cancer; 1996 Feb; 32A(2):249-54. PubMed ID: 8664036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.